Abstract PD4-10: The prognosis of invasive early hormone receptor positive HER2 negative breast cancer in women harboring a pathogenic or likely pathogenic TP53 germline variant
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: Hospital Sírio-Libanês, Dana-Farber Cancer Institute, University of Padua, University of Pennsylvania, DASA (Brazil), Institut Gustave Roussy, Institut Paoli-Calmettes, Centre Léon Bérard, Azienda Ospedaliero-Universitaria di Modena, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129212060
Cites:
Cited by:
Related to: